Session Abstract – PMWC 2022 Silicon Valley

Track 1, June 29


For truly personalized cell and gene therapies to become standard of care, we must continue to leverage and successfully implement advances in science, technology, automation and digitization to scale the process and shorten the time it takes to get lifesaving medicines to patients in need.

 Session Chair Profile

Ph.D., Chief Business Development Officer, Adaptive Biotechnologies

Biography
Dr. Sharon Benzeno is the Chief Business Development Officer and leads the Drug Discovery group at Adaptive. Sharon oversees the use of the company’s immune medicine platform for novel drug discovery, including TCR discovery to inform next-generation cellular therapy, antibody discovery, and vaccines. Before joining Adaptive in 2014, Sharon was Senior Director at Elsevier Inc., a healthcare informatics company. Prior to Elsevier, Sharon co-led the oncology business unit at Capgemini SE, a consulting and technology services company. Sharon came to Elsevier from Capgemini, where she held a variety of management roles at AstraZeneca plc. Sharon holds a PhD in Biomedical Sciences from New York University School of Medicine, an MBA in Finance and Leadership from New York University Stern School of Business and a BA in Biochemistry from New York University. Sharon completed a postdoctoral fellowship in cancer biology at the University of Pennsylvania Abramson Cancer Center.

Talk
Next-generation Supply Chain For Cell & Gene Therapies
For truly personalized cell and gene therapies to become standard of care, we must continue to leverage and successfully implement advances in science, technology, automation and digitization to scale the process and shorten the time it takes to get lifesaving medicines to patients in need.


 Speaker Profile

M.B.A., CEO, Vineti

Biography
Ann brings more than 25 years of healthcare technology product strategy, management, sales and marketing experience to Vineti. Ann served as Chief Product Officer for Tact.ai, a leading CRM company focused on the life sciences industry. She also served as Chief Product Officer and Partner for ZS Associates and as Vice President and General Manager, Healthcare, for Vlocity (now Salesforce Industries). Earlier in her career, Ann held positions of increasing responsibility in the healthcare technology industry, including as Senior Vice President of Product Management for Risk Management Solutions, General Manager of Insurance and Healthcare at Siebel Systems (acquired by Oracle), and Senior Manager of healthcare strategy at Accenture. She also currently serves as an advisory board member for Capsico Health.


 Speaker Profile

President and Chief Operations Officer, PACT Pharma

Biography
Tim Moore has more than three decades of leadership experience in biopharmaceutical manufacturing and operations. Mr. Moore is current the President and Chief Operating Officer at PACT Pharma. Prior to joining PACT, he served as Executive Vice President, Technical Operations at Kite, a Gilead Company, since March of 2016. During this time Mr. Moore was responsible for overseeing the process development, manufacturing, quality and supply chain for the launch of Yescarta®, one of the first CAR T therapies. Prior to Kite, Mr. Moore served as the Senior Vice President, Head of Global Technical Operations – Biologics of Genentech, Inc. . In this role, Mr. Moore oversaw global leadership across 10 internal sites and over 37 contract manufacturing organizations, as well as global manufacturing and end-to-end quality supply performance of more than 20 biological product families. Prior to that, Mr. Moore was Genentech’s Senior Vice President, Global Supply Chain and Global Engineering from 2007 to 2010.


 Speaker Profile

President, Specialty Solutions, Cardinal Health

Biography
Heidi Hunter is President of Cardinal Health Specialty Solutions, a specialty healthcare business that helps healthcare providers and pharmaceutical companies optimize business success and drive improved patient care. Heidi is an accomplished global healthcare leader with deep experience in innovation, development and commercialization of specialty pharmaceuticals. She began her career in sales and marketing at Ciba-Geigy in Switzerland, then moved to Novo Nordisk in Denmark and later Wyeth (today part of Pfizer) in the US where she led their oncology business. She served as Senior Vice President and General Manager at Boehringer Ingelheim where she built and led their global biosimilars business. She also held senior leadership roles in marketing and commercialization for biologics and oncology at Centocor, a J&J company. Most recently, she was Senior Vice President of the Global Immunology business unit at UCB in Brussels. Heidi holds an MBA from The University of Chicago.